Table 2 Baseline demographics between patients with MVI and without MVI after propensity score matching(PSM)
MVI(+) | MVI(−) | p value | ||
|---|---|---|---|---|
n = 187 | n = 187 | |||
Age > 60y | 35(18.7) | 36(19.3) | 1.000 | |
Gender(male/female) | 169/18 | 168/19 | 1.000 | |
Positive HBsAg | 171(91.4) | 171(91.4) | 1.000 | |
Positive HBV-DNA load(>10^3 IU/ml) | 92(49.2) | 92(49.2) | 1.000 | |
AFP(> 400 ng/ml) | 98(52.4) | 94(50.3) | 0.756 | |
Differentiation | poor | 97(51.9) | 95(50.8) | 0.918 |
well-moderate | 90(48.1) | 92(49.2) | ||
Satellite lesion | 37(19.8) | 31(16.6) | 0.503 | |
Tumor number** | one | 134(71.7) | 134(71.7) | 0.620 |
two | 27(14.4) | 32(17.1) | ||
more | 26(13.9) | 21(11.2) | ||
Tumor size(cm) | 7.5 ± 3.7 | 7.4 ± 3.9 | 0.924 | |
Ishak score | 5–6 | 126(67.4) | 128(68.4) | 0.912 |
0–4 | 61(32.6) | 59(31.6) | ||
BCLC classification** | A | 138(73.8) | 140(74.9) | 0.906 |
B | 49(26.2) | 47(25.2) | ||
Lg10ALT(U/l)) | 1.6 ± 0.3 | 1.6 ± 0.3 | 0.924 | |
Lg10AST(U/l) | 1.7 ± 0.2 | 1.7 ± 0.2 | 0.871 | |
ALB(g/l) | 41.5 ± 4.2 | 41.6 ± 5.0 | 0.810 | |
TBIL(mmol/l) | 15.0 ± 6.5 | 14.5 ± 6.9 | 0.460 | |
PLR | ≥111 | 77(41.2) | 75(40.1) | 0.916 |
< 111 | 112(59.9) | 110(58.8) | ||
NLR | ≥3 | 62(33.2) | 64(34.2) | 0.913 |
< 3 | 125(66.8) | 123(65.8) | ||
Surgery type | extend | 38(20.3) | 46(24.6) | 0.858 |
major | 74(39.6) | 61(32.6) | ||
minor | 75(40.1) | 80(42.8) | ||
Blood transfusion | 18(9.6) | 16(8.6) | 0.858 | |